written on 07.04.2014

GlaxoSmithKline confronts new bribery allegations, this time in Iraq


Bribery allegations against GlaxoSmithKline are no longer confined to China. New claims have forced the pharma giant to open investigations on a second front, with the company now looking into possible corruption in Iraq, the company said Sunday.